ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SCLP Scancell Holdings Plc

10.10
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.10 9.70 10.50 10.10 9.975 10.10 211,828 08:00:21
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 5.27M -11.94M -0.0129 -7.83 93.71M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 10.10p. Over the last year, Scancell shares have traded in a share price range of 7.65p to 18.125p.

Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £93.71 million. Scancell has a price to earnings ratio (PE ratio) of -7.83.

Scancell Share Discussion Threads

Showing 10876 to 10897 of 66650 messages
Chat Pages: Latest  446  445  444  443  442  441  440  439  438  437  436  435  Older
DateSubjectAuthorDiscuss
23/8/2017
11:36
Blimey - I'm only down 59% now after 5 years!
skinny
23/8/2017
11:32
So Tosh

Now compare that to SCLP's pile of cr4p ????????????????

inanaco
23/8/2017
11:31
Loz ... elbow in ... because I can, and you cannot .. LOL
inanaco
23/8/2017
11:30
tosh i am not AWOL ...

tosh123 - 17 May 2017 - 09:07:08 - 9354 of 10884 Using immunology to fight cancer. - SCLP
IMM rocking and rolling this morning after another update on the current trial.
Thats how a baby bio should be run. Clear news on a regular basis. Clear goals with a clear pathway to achievement. Shareholders treated with respect. Open honest and candid management... Now compare that to SCLP's pile of cr4p.

------------------------------------------------------------

but take IMM the share 5 years ago was about 60p before scancell broke cover

inanaco
23/8/2017
11:28
If there is a case for " debate what ? on the LSE, can you show me any debate ?"
meaning = there is NOTHING to debate or worth ...
Then - WHY have YOU made a few attempts to 'elbow-in' ???
Attempts that , as *WE* see have been met with the COLD SHOULDER from the now AWARE OF YOU users of ELSIE S Central... with whom YOU are trying to 'engage'... and they ....
Throw YOU a deaf un ???

the real lozan
23/8/2017
11:26
Can't read most posts on here - page after page of 'filtered' messages, so apologies if going over old ground. I assume the company must know of something going on, or they'd have had to issue a 'we know of no reason' notice for a climb like this in such a short time? Not sure of what the rules are on responding to sharp falls and rises. Is a partnership deal in the offing?
supernumerary
23/8/2017
11:26
tosh123 - 06 Jun 2017 - 16:18:25 - 9467 of 10884 Using immunology to fight cancer. - SCLP
Looks like today might be the day ! Single figures on their way unfortunately, as predicted by some of us. Just watch the sheep try to justify their stance now, and see how they will try to discredit those who called this right yet again... When will they ever learn... and GF must be bricking it, if indeed he does hold what he says he does, which i very much doubt.
This is now officially a total shambles, the BOD should be ashamed of themselves, especially RG who said that this was the most successful cash raise ever , what a clown !
When / if this breaks 8p, i might buy some more, but lets see what happens, where it goes and how fast it gets there etc.
BOD need to take action now as the 10p threshold is significant.

Big error ...... LOL

inanaco
23/8/2017
11:25
A0469514... As i said, both forums are 100% better with the absence of the village idiot.
I have no interest in engaging the LIAR anymore... So the best thing to do now that he has been exposed, is to ignore him, my work is done as far as he's concerned.

tosh123
23/8/2017
11:24
Mr Guff - "A 'bit' of hype is OK, IF it is 'natural enthusiasm' and GENUINE"A bit of scepticism is ok too, if it doesn't become repetitive negative dogma. Repetition of the point "it needs funding" without offering any price at which the stock becomes attractive, constitutes such dogma. I hope nobody locked in losses at the lows, or were dissuaded from buying at the lows, as a result of such posts.
wigwammer
23/8/2017
11:13
Tosh debate what ? on the LSE, can you show me any debate ?


the only opinion you have given is just the same old repeat ...

inanaco
23/8/2017
11:08
A0469514... and there in lies a tale.
As with C7's forum on the other place, the absence of a certain village idiot means that normal people can debate and exchange views without his destructive and uneducated LIES taking centre stage.
I welcome his absence with open arms, long may it continue.

tosh123
23/8/2017
11:07
Does it make any difference Tosh for you, you have already said you would not buy in at 10p
Loz have you dipped your toe in yet ? or you still waiting the funding ?

inanaco
23/8/2017
10:34
J777J,
which then begs the question, after 4 - 5 years, " why no deal " ?
Not being negative , but it is a question that many people ponder over.
If the industry is gushing with cash, and the potential market is in excess of $200 bill, and Scancells science is so nailed on, it beggars belief that RG has not managed to strike a deal.

tosh123
23/8/2017
10:28
A minnow in an industry gushing with cash.Panmure's albeit conservative 58p odd price target has factored some of that in.
j777j
23/8/2017
10:27
J777J,
IMHO, the use of the word " will " is a tad presumptuous.
None of us know for sure whether this will ever get to the stage where it is a recommended and prescribed treatment. There are still far too many unknowns at this stage.
Of course, if your statement was a nailed on certainty, then the share price would reflect that fact, but as is evident, 13p indicates and reinforces the fact that there is still a lot of work to be done before we can relax.
As for Panmures target price, i would take any brokers price as a thing of myth.
They have a vested interest to come up with a healthy looking target price, and in most cases, they are wildly inaccurate.
Just my thoughts though, others will no doubt have their own very plausible and differing views.

tosh123
23/8/2017
10:18
Raindrop -
Good post
A 'bit' of hype is OK, IF it is 'natural enthusiasm' and GENUINE
When hype becomes trHYPE based on 'intentional' FAKE / FALSE CLAIMS... it takes on a different role... One where the 'perpetrators' aim is deceive others - for THEIR own gain.
Good to see the question of FUNDING is now accepted and prominent in most shareholders/posters thinking

the real lozan
23/8/2017
10:00
8 cancer patients slive and well after 5 years.That is what has changed.Funding for a co that will exceed a billion dollars imkt cap n a few years,will not be an issue.Panmures price target was already around 58p
j777j
23/8/2017
09:59
MTB4 -As I tried to convey to you yesterday- it is very difficult to value an early stage biotech asset, where all the usual yardsticks of valuation are missing like earnings, sales, equity and so on.Sentiment is key - which is why I have repeatedly stated that the lack of hype either here or on the lse board is in itself important.Yes, they have to raise funds and that will likely result in weakness, but from what price level? The weakness in sentiment and technical overhang has now resulted in a considerable bounce which was predictable and at 30%+ meaningful.
wigwammer
23/8/2017
09:52
Interesting article hot off the press, if anyone wants to read it ;-

Scientists are developing an artificial intelligence based system to help detect melanoma - a deadly form of skin cancer - in its early stages.
The system, built by researchers at University of Waterloo in Canada, analyses images of skin lesions and provides doctors with data on telltale biomarkers of melanoma, which is deadly if detected late, but highly treatable if caught early.
It deciphers levels of biomarker substances in lesions, adding consistent, quantitative information to assessments currently based on appearance alone, researchers said.
In particular, changes in the concentration and distribution of eumelanin, a chemical that gives skin its colour, and hemoglobin, a protein in red blood cells, are strong indicators of melanoma, they said.
The artificial intelligence (AI) system - trained using tens of thousands of skin images and their corresponding eumelanin and hemoglobin levels - could initially reduce the number of unnecessary biopsies, a significant health-care cost, researchers said.
It gives doctors objective information on lesion characteristics to help them rule out melanoma before taking more invasive action.
"This could be a very powerful tool for skin cancer clinical decision support. The more interpretable information there is, the better the decisions are," said Alexander Wong, a professor of systems design engineering at Waterloo.
"There can be a huge lag time before doctors even figure out what is going on with the patient. Our goal is to shorten that process" Wong added.

tosh123
23/8/2017
09:41
JJ
I hate to think how many times over the years I have heard exactly that - what has fundamentally changed - the arrival of new shareholders I suppose

tosh, lozan, inanaco - if you have replied I haven't seen it as I filtered you many weeks ago - I appreciate facts NOT endless arguments

mikethebike4
23/8/2017
09:29
B,
unfortunately, he has lost all credibility from my stand point, but thats just a personal observation. However, it does appear to be somewhat timely that the article is printed a few weeks before the AGM, especially as one would think that any news on funding will have to be published prior to the impending AGM, otherwise the BOD will have a very rough ride, and maybe even have calls for resignations IMHO.
I agree that the resolution of the Helium selling is also somewhat instrumental in the share price rise, but it doesn't account for the additional volume, i think the article is responsible for that.
Anyway, its all pure speculation, and i reiterate, i hope im wrong.

tosh123
23/8/2017
09:18
Blimey he's damned if he does and damned if he doesn't. Of course RG will be promoting Scancell as heavily as possible in advance of the next funding - that is his job!! You'd be the first to moan about lack of PR, lack of effort to support sharholders if he didn't. The job of any CEO is to raise awareness and get across the investment rationale for their Company - there is nothing whatsoever wrong with that and I have no idea why you would try to find any negative in that let alone raise the question of insider dealing.

The reason for the rise is very simple, Helium appear to be out so selling has stopped, we know there are several major pieces of news due in Q3 and sentiment has returned.

bermudashorts
Chat Pages: Latest  446  445  444  443  442  441  440  439  438  437  436  435  Older